Larvol Delta - Vopratelimab-JTX2011-Alone-and-in-Combination-With-AntiProgrammed-Cell-Death-Protein-1-PD1-or-AntiCytotoxic-TLymphocyte-Antigen-4-CTLA4-in-Subjects-With-Advanced-andor-Refractory-Solid-Tumors

Yervoy (ipilimumab) - BMS

Opdivo (nivolumab) - BMS

vopratelimab (JTX-2011) - Concentra Biosci

http://clinicaltrials.gov/ct2/show/NCT04319224

May 30, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next